局限性前列腺癌男性经济负担：过程论文表1

数据集获取（Figshare）

• 源站标题：Table_1_Financial burden of men with localized prostate cancer: a process paper.pdf
• DOI：10.3389/fpsyg.2023.1176843.s001
• 发布日期：2023-09-25
• 文件数：1 个
• 文件总体积：185.87 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/Table_1_Financial_burden_of_men_with_localized_prostate_cancer_a_process_paper_pdf/24192114

命令行下载

curl -L -o "Table_1_Financial burden of men with localized prostate cancer: a process paper.pdf" "https://ndownloader.figshare.com/files/42449214"

文件清单

• Table_1_Financial burden of men with localized prostate cancer: a process paper.pdf（185.87 KB）

文件总体积 185.87 KB（源站 API 实测）。

数据说明

BackgroundMany individuals undergoing cancer treatment experience substantial financial hardship, often referred to as financial toxicity (FT). Those undergoing prostate cancer treatment may experience FT and its impact can exacerbate disparate health outcomes. Localized prostate cancer treatment options include: radiation, surgery, and/or active surveillance. Quality of life tradeoffs and costs differ between treatment options. In this project, our aim was to quantify direct healthcare costs to support patients and clinicians as they discuss prostate cancer treatment options. We provide the transparent steps to estimate healthcare costs associated with treatment for localized prostate cancer among the privately insured population using a large claims dataset.
MethodsTo quantify the costs associated with their prostate cancer treatment, we used data from the Truven Health Analytics MarketScan Commercial Claims and Encounters, including MarketScan Medicaid, and peer reviewed literature. Strategies to estimate costs included: (1) identifying the problem, (2) engaging a multidisciplinary team, (3) reviewing the literature and identifying the database, (4) identifying outcomes, (5) defining the cohort, and (6) designing the analytic plan. The costs consist of patient, clinician, and system/facility costs, at 1-year, 3-years, and 5-years following diagnosis.
ResultsWe outline our specific strategies to estimate costs, including: defining complex research questions, defining the study population, defining initial prostate cancer treatment, linking facility and provider level related costs, and developing a shared understanding of definitions on our research team.
Discussion and next stepsAnalyses are underway. We plan to include these costs in a prostate cancer patient decision aid alongside other clinical tradeoffs.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fpsyg.2023.1176843.s001（source: https://frontiersin.figshare.com/articles/dataset/Table_1_Financial_burden_of_men_with_localized_prostate_cancer_a_process_paper_pdf/24192114）。